Official UK visa sponsor profile for Ipsen Biopharm Limited in Wrexham, including current register status, route details, and public company data.
Ipsen Biopharm Limited is a global biopharmaceutical company established in 1982, currently operating under Reg. 01653765. Located at Ash Road, Wrexham, LL13 9UF, Ipsen specializes in the research, development, and commercialization of innovative specialty therapies. The company’s core focus lies in addressing unmet medical needs through the creation of novel pharmaceutical products. Ipsen’s international presence is significant, encompassing a network of research and development centers and commercial operations across North America, Europe, and Asia. The company’s size is estimated to be a mid-sized enterprise, representing a dedicated team of scientists, clinicians, and business professionals. Ipsen’s primary service offering centers around the development of specialized treatments for a range of therapeutic areas, including oncology, immunology, and rare diseases. The company’s key focus is on delivering differentiated therapies with a strong emphasis on patient outcomes. The company’s SIC codes encompass the manufacturing of basic pharmaceutical products, aligning with its core business model. Ipsen actively utilizes Visa for Global Business Mobility, indicating a commitment to international collaboration and strategic partnerships.
Official UK visa sponsor profile for Ipsen Biopharm Limited in Wrexham, including current register status, route details, and public company data.
Ipsen Biopharm Limited is a global biopharmaceutical company established in 1982, currently operating under Reg. 01653765. Located at Ash Road, Wrexham, LL13 9UF, Ipsen specializes in the research, development, and commercialization of innovative specialty therapies. The company’s core focus lies in addressing unmet medical needs through the creation of novel pharmaceutical products. Ipsen’s international presence is significant, encompassing a network of research and development centers and commercial operations across North America, Europe, and Asia. The company’s size is estimated to be a mid-sized enterprise, representing a dedicated team of scientists, clinicians, and business professionals. Ipsen’s primary service offering centers around the development of specialized treatments for a range of therapeutic areas, including oncology, immunology, and rare diseases. The company’s key focus is on delivering differentiated therapies with a strong emphasis on patient outcomes. The company’s SIC codes encompass the manufacturing of basic pharmaceutical products, aligning with its core business model. Ipsen actively utilizes Visa for Global Business Mobility, indicating a commitment to international collaboration and strategic partnerships.
Yes, Ipsen Biopharm Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Ipsen Biopharm Limited is classified under: Manufacture of basic pharmaceutical products.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, Ipsen Biopharm Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Ipsen Biopharm Limited is classified under: Manufacture of basic pharmaceutical products.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.